[
    [
        {
            "time": "2021-10-15",
            "original_text": "药明康德：第三季度激励对象行权且完成股份过户登记的数量为58.3万股",
            "features": {
                "keywords": [
                    "药明康德",
                    "激励对象",
                    "行权",
                    "股份过户"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "药明康德：第三季度激励对象行权且完成股份过户登记的数量为58.3万股",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-10-16",
            "original_text": "药明康德：332名激励对象已自行决定就调整后首次授予第一个行权期授出的部分股票期权行权",
            "features": {
                "keywords": [
                    "药明康德",
                    "激励对象",
                    "行权",
                    "股票期权"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "药明康德：332名激励对象已自行决定就调整后首次授予第一个行权期授出的部分股票期权行权",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-10-17",
            "original_text": "药明康德（603259.SH）：多名高管完成减持30.68万股 减持股份",
            "features": {
                "keywords": [
                    "药明康德",
                    "高管",
                    "减持",
                    "股份"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "药明康德（603259.SH）：多名高管完成减持30.68万股 减持股份",
                "Correlation": 10,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-10-18",
            "original_text": "北向资金今日净卖出25.72亿元，贵州茅台遭大幅净卖出超11亿元",
            "features": {
                "keywords": [
                    "北向资金",
                    "净卖出",
                    "贵州茅台"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "白酒"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "北向资金今日净卖出25.72亿元，贵州茅台遭大幅净卖出超11亿元",
                "Correlation": 3,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-10-19",
            "original_text": "药明康德：胡正国、杨青、陈民章等董事、高管减持计划已实施完毕",
            "features": {
                "keywords": [
                    "药明康德",
                    "董事",
                    "高管",
                    "减持计划"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "药明康德：胡正国、杨青、陈民章等董事、高管减持计划已实施完毕",
                "Correlation": 10,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-10-20",
            "original_text": "港股生物医药板块走高，百济神州涨近4%，康哲药业涨近3%，药明康德涨超2%",
            "features": {
                "keywords": [
                    "港股",
                    "生物医药",
                    "百济神州",
                    "康哲药业",
                    "药明康德"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "港股生物医药板块走高，百济神州涨近4%，康哲药业涨近3%，药明康德涨超2%",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 9,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-10-21",
            "original_text": "医药行业周报：医药“淡季”不“淡” 关注三季报预期",
            "features": {
                "keywords": [
                    "医药行业",
                    "周报",
                    "三季报",
                    "预期"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "医药行业周报：医药“淡季”不“淡” 关注三季报预期",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-10-22",
            "original_text": "医药行业周报：国庆期间海外抗疫板块出现波动 建议理性看待新冠口服药影响",
            "features": {
                "keywords": [
                    "医药行业",
                    "周报",
                    "抗疫板块",
                    "新冠口服药"
                ],
                "sentiment_score": -0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "医药行业周报：国庆期间海外抗疫板块出现波动 建议理性看待新冠口服药影响",
                "Correlation": 4,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        }
    ]
]